BIOLASE Inc
General ticker "BIOL" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $570.9K
BIOLASE Inc does not follow the US Stock Market performance with the rate: -42.7%.
Estimated limits based on current volatility of 34.1%: low 0.00$, high 0.01$
Factors to consider:
- Earnings expected soon, date: 2024-11-14
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.14$, 6.82$]
- 2024-12-30 to 2025-12-30 estimated range: [1.92$, 5.43$]
Financial Metrics affecting the BIOL estimates:
- Negative: Non-GAAP EPS, $ of -32.58 <= 0.12
- Negative: Operating profit margin, % of -26.73 <= 1.51
- Negative: Operating cash flow per share per price, % of -90.29 <= 2.52
- Negative: Industry operating cash flow per share per price (median), % of -3.56 <= 3.96
- Negative: Return on assets ratio (scaled to [-100,100]) of -37.02 <= 0
- Negative: Industry operating profit margin (median), % of -17.94 <= 2.29
- Negative: Interest expense per share, $ of 1.85 > 0.47
Short-term BIOL quotes
Long-term BIOL plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $39.19MM | $48.46MM | $49.16MM |
| Operating Expenses | $55.62MM | $73.80MM | $67.10MM |
| Operating Income | $-16.43MM | $-25.34MM | $-17.94MM |
| Non-Operating Income | $0.34MM | $-3.19MM | $-2.66MM |
| Interest Expense | $2.22MM | $2.75MM | $2.36MM |
| R&D Expense | $6.05MM | $7.26MM | $6.00MM |
| Income(Loss) | $-16.09MM | $-28.52MM | $-20.60MM |
| Taxes | $0.07MM | $0.11MM | $0.03MM |
| Profit(Loss) | $-16.16MM | $-28.63MM | $-20.63MM |
| Stockholders Equity | $25.21MM | $4.89MM | $-0.25MM |
| Inventory | $12.93MM | $15.88MM | $11.43MM |
| Assets | $55.28MM | $38.19MM | $35.10MM |
| Operating Cash Flow | $-16.71MM | $-26.76MM | $-14.09MM |
| Investing Cash Flow | $-0.71MM | $-3.73MM | $-1.13MM |
| Financing Cash Flow | $29.95MM | $4.60MM | $17.43MM |
| Earnings Per Share* | $-273.41 | $-413.19 | $-16.14 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.